Shanghai Pharmaceuticals Holding Co., Ltd
Shanghai Pharmaceuticals Holding Co., Ltd
Your view on SHPMF
Overview
What the company does, where it operates, and who runs it.
About Shanghai Pharmaceuticals Holding Co., Ltd
- Industry
- Medical - Distribution
- Sector
- Healthcare
- CEO
- Qiuhua Yang
- Headquarters
- Shanghai Pharmaceutical Building, Shanghai, CN
- Industry
- Medical - Distribution
- Sector
- Healthcare
- CEO
- Qiuhua Yang
- Headquarters
- Shanghai Pharmaceutical Building, Shanghai, CN
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others.
The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs.
The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies.
In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals.
Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Shanghai Pharmaceuticals Holding Co., Ltd, and the rating behind it. SHPMF last traded at $1.46, 12.6× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Shanghai Pharmaceuticals Holding Co., Ltd. Starting points for Shanghai Pharmaceuticals Holding Co., Ltd: P/E 12.6, EPS $1.29, beta 0.35 — an Medical - Distribution name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Shanghai Pharmaceuticals Holding Co., Ltd. Shanghai Pharmaceuticals Holding Co., Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Shanghai Pharmaceuticals Holding Co., Ltd. Trailing twelve-month EPS for Shanghai Pharmaceuticals Holding Co., Ltd stands at $1.29. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Shanghai Pharmaceuticals Holding Co., Ltd. Shanghai Pharmaceuticals Holding Co., Ltd has reported as a listed company since 2013. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Shanghai Pharmaceuticals Holding Co., Ltd valued side by side against its closest peers. Shanghai Pharmaceuticals Holding Co., Ltd is measured against Medical - Distribution peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Shanghai Pharmaceuticals Holding Co., Ltd, and how their positions are changing. At a $8.46B market value, institutional positions materially move Shanghai Pharmaceuticals Holding Co., Ltd's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Shanghai Pharmaceuticals Holding Co., Ltd executives and directors. Shares of Shanghai Pharmaceuticals Holding Co., Ltd have traded between $1.46 and $15.70 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Shanghai Pharmaceuticals Holding Co., Ltd. Shanghai Pharmaceuticals Holding Co., Ltd is a $8.46B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Shanghai Pharmaceuticals Holding Co., Ltd. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Shanghai Pharmaceuticals Holding Co., Ltd. Coverage tracks Shanghai Pharmaceuticals Holding Co., Ltd within Medical - Distribution (Healthcare). Press releases and market coverage, newest first.